Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer

Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer

Pivot’s microbial technology will allow farmers to reduce the use of fertilizers, which can generate potent greenhouse gases.

BriaCell Announces Positive Phase IIa Data in Advanced Breast Cancer

BriaCell Announces Positive Phase IIa Data in Advanced Breast Cancer

To further investigate anti-tumor activity, Briacell will explore combination therapies.

Principia Biopharma announces $100M IPO

Principia Biopharma announces $100M IPO

Principia is a spinoff from Jack Taunton’s lab at UCSF.

Atreca Raises $125 Million

Atreca Raises $125 Million

Atreca was one of the first companies in Mission Bay Capital’s portfolio.

FDA Grants Breakthrough Therapy Designation for Concentric Analgesics’ CA-008 in Post-Surgical Pain

FDA Grants Breakthrough Therapy Designation for Concentric Analgesics’ CA-008 in Post-Surgical Pain

The drug is an alternative to opiates.

Synvitrobio rebrands & raises cash

Synvitrobio rebrands & raises cash

Under its new name, Tierra Biosciences, the company will focus on agricultural and biochemical products.

Newomics Closes $3.9M Series A Round

Newomics Closes $3.9M Series A Round

Newomics will use the funds to expand the team and commercialize its silicon-based multinozzle emitter array technology.

Pivot Bio aims to stem red tides

Pivot Bio aims to stem red tides

Pivot’s crop probiotics prevent the nitrate runoff that causes algal blight in waterways.

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

The collaboration will advance polypharmacology in drug discovery using AI-augmented technology.

Principia Biopharma files for an $86 million IPO

Principia Biopharma files for an $86 million IPO

Principia plans to list on the Nasdaq under the symbol PRNB.

$700 Million Bolt Threads May Have Cracked The Code On Spider Silk

$700 Million Bolt Threads May Have Cracked The Code On Spider Silk

Wary of failing in public, they worked in stealth at the QB3 Garage for 5 years.

Alector raises $133M to push neuro-immunology drugs into Alzheimer’s trials

Alector raises $133M to push neuro-immunology drugs into Alzheimer’s trials

With this much investor interest, the round keeps Alector's options open, CBO Sabah Oney says. 

Raydiant Oximetry raises $1 million seed round, secures NIH funding

Raydiant Oximetry raises $1 million seed round, secures NIH funding

Raydiant was a 2017 Rosenman Innovator.

Lygos closes $15.5M Series B round

Lygos closes $15.5M Series B round

The funds will accelerate commercialization of pipelined products and expand Lygos’s technology platform.

Diassess wins $21.9M federal contract for home flu test

Diassess wins $21.9M federal contract for home flu test

The funding will take home & clinical tests through clinical trials and submissions for FDA clearance.

Lygos a winner of inaugural "Consider Corn" Challenge

Lygos a winner of inaugural "Consider Corn" Challenge

The competition spotlights technology to convert corn into bio-renewable chemicals.

ViewPoint Therapeutics Raises $35 Million Series B

ViewPoint Therapeutics Raises $35 Million Series B

ViewPoint's technology prevents and treats cataracts and presbyopia.

QB3's "Pop-Up Institutes" Efficient Way to Tackle Big Challenges

QB3's "Pop-Up Institutes" Efficient Way to Tackle Big Challenges

Our pop-up institute on fibrosis convenes April 26 at UCSF.

QB3@953 changes name to "MBC Biolabs"

QB3@953 changes name to "MBC Biolabs"

The successful QB3 spinout is making the name change as part of a rebranding and expansion.